Bausch Health
BHC
5,85 €
Share price
-2.69%
Change (1 day)
-13.05%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Bausch Health (BHC) - Total assets
Total assets on the balance sheet as of March 2025 : €22.50 Billion
According to Bausch Health 's latest financial reports the company's total assets are €22.50 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Bausch Health - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | €25.48 B | 3.02% |
| 2023-12-31 | €24.74 B | 3.32% |
| 2022-12-31 | €23.94 B | -7.13% |
| 2021-12-31 | €25.78 B | 1.66% |
| 2020-12-31 | €25.36 B | -16.09% |
| 2019-12-31 | €30.22 B | 6.43% |
| 2018-12-31 | €28.40 B | -9.12% |
| 2017-12-31 | €31.25 B | -24.48% |
| 2016-12-31 | €41.38 B | -7.59% |
| 2015-12-31 | €44.78 B | 107.05% |
| 2014-12-31 | €21.62 B | 6.79% |
| 2013-12-31 | €20.25 B | 49.25% |
| 2012-12-31 | €13.57 B | 34.44% |
| 2011-12-31 | €10.09 B | 24.37% |
| 2010-12-31 | €8.11 B | 464.64% |
| 2009-12-31 | €1.43 B | 23.76% |
| 2008-12-31 | €1.16 B | -4.85% |
| 2007-12-31 | €1.22 B | -26.54% |
| 2006-12-31 | €1.66 B | -2.98% |
| 2005-12-31 | €1.71 B | 35.77% |
| 2004-12-31 | €1.26 B | -30.88% |
| 2003-12-31 | €1.82 B | 4.03% |
| 2002-12-31 | €1.75 B | 16.36% |
| 2001-12-31 | €1.50 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | €15.48 M | -99.93% | 🇺🇸 USA |
 OPKO Health
OPK | €1.81 B | -91.94% | 🇺🇸 USA |